NBIX vs OII · P/E 45, rev $1.77B vs P/E 11, rev $1.46B
Neurocrine Biosciences Inc (NBIX) versus Oceaneering International Inc (OII) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Oceaneering International Inc (OII) is a oil & gas equipment & services company listed on NYSE.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported OII revenue for 2026-06-30 was $1.46B. Net income was $101.1M. OII currently screens at market cap $3.54B and trailing P/E 10.7.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. OII currently screens at market cap $3.54B and trailing P/E 10.7.
Not investment advice. Open the NBIX and OII stock pages for the full models.
Not investment advice.